Biologics Infographic: Real-time Patient Insights from Medisafe
Highlights from the Biologics Infographic
- The U.S. trails other nations in reported biologic medication adherence on Medisafe
- Since many biologics are scheduled at an infusion center, reported adherence stays consistently high each weekday
- The hourly peaks at 7am and 9pm suggest people using Medisafe are scheduling their infusions before or after work hours
- Worldwide medication adherence rates for most biologic conditions average 81% on Medisafe
- Of the top 20 biologic drugs with the highest reported adherence on Medisafe, Amgen, Biogen and Genentech each hold 3 spots
What insights can we discover about your brand? Contact us to find out!
Full Biologics Adherence Insights
Top 10 Most Adherent Countries For Biologic Meds
- Germany: 85%
- France: 83%
- Spain: 83%
- UK: 80%
- Australia: 78%
- Canada: 78%
- Brazil: 76%
- India: 75%
- USA: 71%
- Italy: 68%
How Day Of Week Affect Biologic Med Adherence
- Sunday: 80.9%
- Monday: 81.01%
- Tuesday: 80.84%
- Wednesday: 80.92%
- Thursday: 80.95%
- Friday: 80.82%
- Saturday: 80.81%
Adherence Rates By Type Of Biologic Treatment
- Hematology & Transplant Rejection: 88%
- Infections: 87%
- Cardiovascular: 82%
- Diabetes / Other Metabolic Conditions: 82%
- Autoimmune Diseases: 81%
- Eye Conditions: 81%
- Neurological: 72%
Why Biologic Patients Say They Miss Doses
- Didn’t need dose: 25%
- Forgot/busy: 20%
- Other: 20%
- Med wasn’t nearby: 18%
- Ran out of meds: 10%
- Worried about side effects: 6%
- Worried about cost: 2%
Top 20 Biologic Meds With Highest Adherence
Brand | Company | Adherence |
Plegridy | Biogen | 92% |
Neulasta | Amgen | 90% |
Extavia | Novartis | 89% |
Kineret | Sobi | 88% |
Cimzia | UCB | 87% |
Pegasys | Genentech | 87% |
Avonex | Biogen | 87% |
Rebif | EMD Serono | 86% |
Actemra | Genentech | 86% |
Orencia | BMS | 86% |
Humira | AbbVie | 85% |
Trulicity | Eli Lilly | 84% |
Praluent | Sanofi & Regeneron | 82% |
Repatha | Amgen | 82% |
Simponi | Janssen | 81% |
Avastin | Genentech | 81% |
Enbrel | Amgen | 81% |
Tanzeum | GSK | 80% |
Cosentyx | Novartis | 78% |
Tysabri | Biogen | 78% |